SYNTHESIS OF NOVEL MPTP ANALOGS AS POTENTIAL MONOAMINE OXIDASE-B (MAO-B) INHIBITORS

被引:44
作者
KALGUTKAR, AS [1 ]
CASTAGNOLI, N [1 ]
机构
[1] VIRGINIA POLYTECH INST & STATE UNIV, DEPT CHEM, BLACKSBURG, VA 24061 USA
关键词
D O I
10.1021/jm00100a023
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is an excellent substrate and a weak inactivator of the flavoenzyme monoamine oxidase B (MAO-B). In an attempt to develop novel mechanism-based inactivators of MAO-B, we have synthesized analogs of MPTP bearing a variety of functional groups at either the N or the C (4) position and have examined their interactions with a purified MAO-B preparation isolated from beef liver. The substituents selected include allyl, propargyl, ethenyl, ethynyl, and cyclobutyl, that is, functionalities which were considered potential sources of enzyme generated electrophilic or radical intermediates that might alkylate and inactivate the enzyme. None of the C(4)-substituted compounds displayed significant enzyme inhibitor properties although some proved to be good substrates. In the N-substituted MPTP series only the 4-phenyl-1-propargyl analog was a good inhibitor. The time- and concentration-dependent inhibition of MAO-B displayed by this compound is consistent with a mechanism-based inactivation pathway and the catalytic mechanism currently held for monoamine oxidases. The results of these studies provide additional insights into the steric features of the active site of MAO-B and predict that the area in which the C (4) substituent of the tetrahydropyridine ring resides lacks a reactive nucleophilic group.
引用
收藏
页码:4165 / 4174
页数:10
相关论文
共 56 条
[1]   QUANTITATIVE STRUCTURE METABOLISM RELATIONSHIP ANALYSES OF MAO-MEDIATED TOXICATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE AND ANALOGS [J].
ALTOMARE, C ;
CARRUPT, PA ;
GAILLARD, P ;
ELTAYAR, N ;
TESTA, B ;
CAROTTI, A .
CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (03) :366-375
[2]   INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY [J].
BIRKMAYER, W ;
KNOLL, J ;
RIEDERER, P ;
YOUDIM, MBH ;
HARS, V ;
MARTON, J .
JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :113-127
[3]   INTERACTION OF MONOAMINE OXIDASE-B WITH ANALOGS OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE DERIVED FROM PRODINE-TYPE ANALGESICS [J].
BROSSI, A ;
GESSNER, WP ;
FRITZ, RR ;
BEMBENEK, ME ;
ABELL, CW .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (04) :444-445
[4]   FURTHER EXPLORATIONS OF UNNATURAL ALKALOIDS [J].
BROSSI, A .
JOURNAL OF NATURAL PRODUCTS, 1985, 48 (06) :878-893
[5]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[6]   POTENTIAL BIOACTIVATION PATHWAYS FOR THE NEUROTOXIN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) [J].
CASTAGNOLI, N ;
CHIBA, K ;
TREVOR, AJ .
LIFE SCIENCES, 1985, 36 (03) :225-230
[7]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[8]  
CHIBA K, 1985, DRUG METAB DISPOS, V13, P342
[9]  
Ciana L.D., 1984, J HETEROCYCLIC CHEM, V21, P607
[10]   PARGYLINE AND DEPRENYL PREVENT THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MONKEYS [J].
COHEN, G ;
PASIK, P ;
COHEN, B ;
LEIST, A ;
MYTILINEOU, C ;
YAHR, MD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (01) :209-210